Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

You just have to step into your local chemist to see how far medicine has come over the past 100 years. Life-changing drugs, which were once unthinkable – like antibiotics, insulin and the contraceptive pill – are now commonplace. But there's still so much we don't know about the medicines we take.

Drug companies are struggling to keep up with the rising demand for new medicines because of the competitive, timely and costly nature of the drug discovery pipeline. In order to deliver new medicines to the people who need them the most, researchers and drug companies need to work together to speed up the process of drug discovery.

By opening up access to newly discovered protein structures and drug targets, Oxford researchers are doing just that.